Also trades as: CYYNF (OTC) · $vol 0M
CYP.AX ASX
Cynata Therapeutics Limited
1W: +0.0%
1M: +0.0%
3M: -21.4%
YTD: -97.1%
1Y: -94.9%
3Y: -91.5%
5Y: -98.1%
A$0.01 ($0.01)
-0.00 (-0.00%)
Weekly Expected Move ±3.4%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$7M
+22.8% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$7M
+23.2% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$4M
-259.3% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$5M | -$14M | -$10M | $0 | -$9M |
| Depreciation & Amort. | $280K | $280K | $0 | $0 | $260K |
| Stock-Based Comp. | $1M | $327K | $0 | $0 | $130K |
| Change in Working Capital | $1M | -$684K | -$726K | $127K | $0 |
| Other Non-Cash Items | $448K | $2M | $511K | -$9M | $2M |
| Operating Cash Flow | -$3M | -$14M | -$10M | -$9M | -$7M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | -$50K | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$50K | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | -$522K | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $210K | $0 | $0 | $0 | $3M |
| Financing Cash Flow | $210K | $7M | $0 | $8M | $3M |
| Net Change in Cash | -$3M | -$8M | -$10M | -$1M | -$4M |
| Cash End of Period | $24M | $16M | $6M | $5M | $897K |
| Free Cash Flow | -$3M | -$14M | -$10M | -$9M | -$7M |